DIRC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.631400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.086600E-01
Normal-vs-Stage2
7.021400E-01
Normal-vs-Stage3
8.475600E-01
Normal-vs-Stage4
7.827200E-01
Stage1-vs-Stage2
7.787200E-01
Stage1-vs-Stage3
3.375800E-01
Stage1-vs-Stage4
8.959600E-01
Stage2-vs-Stage3
4.196400E-01
Stage2-vs-Stage4
9.292200E-01
Stage3-vs-Stage4
5.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.171600E-01
Normal-vs-AfricanAmerican
7.850800E-01
Normal-vs-Asian
6.611800E-01
Caucasian-vs-AfricanAmerican
8.701800E-01
Caucasian-vs-Asian
3.955400E-01
AfricanAmerican-vs-Asian
7.448800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.328400E-01
Normal-vs-Female
8.239200E-01
Male-vs-Female
5.684400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.664800E-01
Normal-vs-Age(41-60Yrs)
4.253200E-01
Normal-vs-Age(61-80Yrs)
9.827800E-01
Normal-vs-Age(81-100Yrs)
9.983200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.732400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.253200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.215600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.860360E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.148600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.718000E-01
Normal-vs-Daily Drinker
9.608200E-01
Normal-vs-Weekly Drinker
6.687200E-01
Normal-vs-Occasional Drinker
4.220000E-01
Normal-vs-Social Drinker
8.096800E-01
Non Drinker-vs-Daily Drinker
6.047200E-01
Non Drinker-vs-Weekly Drinker
1.573020E-01
Non Drinker-vs-Occasional Drinker
1.326370E-01
Non Drinker-vs-Social Drinker
8.911200E-01
Daily Drinker-vs-Weekly Drinker
3.839600E-01
Daily Drinker-vs-Occasional Drinker
8.464000E-02
Daily Drinker-vs-Social Drinker
7.368800E-01
Weekly Drinker-vs-Occasional Drinker
2.712300E-02
Weekly Drinker-vs-Social Drinker
1.960610E-01
Occasional Drinker-vs-Social Drinker
1.510370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.000360E-01
Normal-vs-Grade 2
3.761600E-02
Normal-vs-Grade 3
3.676300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.963200E-03
Grade 1-vs-Grade 3
2.40309999999244E-05
Grade 1-vs-Grade 4
1.000360E-01
Grade 2-vs-Grade 3
5.509500E-02
Grade 2-vs-Grade 4
3.761600E-02
Grade 3-vs-Grade 4
3.676300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.647000E-01
Normal-vs-NonDiabetic
7.952800E-01
Diabetic-vs-NonDiabetic
7.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.265800E-01
Normal-vs-NoPancreatitis
8.058200E-01
Pancreatitis-vs-NoPancreatitis
1.710020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.724000E-01
Normal-vs-N1
7.416600E-01
N0-vs-N1
9.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.576800E-01
Normal-vs-TP53-NonMutant
9.236800E-01
TP53-Mutant-vs-TP53-NonMutant
1.391600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
